CAD
AERI

Craig A. Drill’s Aerie Pharmaceuticals AERI Stock Holding History

Craig A. Drill’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,200
Closed -$181K – 23
2015
Q3 		$181K Buy
+10,200
New +$185K 0.26% 19

Other funds holding AERI

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Craig A. Drill's AERI Position: Q4 2015 in Review

Craig A. Drill sold out of Aerie Pharmaceuticals (AERI) in Q4 2015, closing a stake of 10,200 shares — an estimated $181K sold.

Craig A. Drill first reported a position in AERI in Q3 2015 and held it in 1 quarter. The position peaked at $181K in Q3 2015. 116 funds tracked by Wall St. Rank hold AERI as of Q4 2015.

  • Craig A. Drill reported no remaining Aerie Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Craig A. Drill sold 10,200 Aerie Pharmaceuticals shares in Q4 2015, an estimated $181K.
  • Craig A. Drill first reported a position in Aerie Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Craig A. Drill's Aerie Pharmaceuticals position peaked at $181K in Q3 2015.
  • 116 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2015.

Based on Craig A. Drill's 13F filing for Q4 2015, filed 11 Feb 2016.